The 2-gene IHC patterns we developed are readily applicable in the clinical setting and may help to differentiate between these two entities, particularly in cases with large CD30+ cell-infiltrated lesions associated with MF disease. This evidence concerns the gene TNFRSF8 and mycosis fungoides.